Medicus Pharma (MDCXW) Equity Ratio (2023 - 2025)
Medicus Pharma (MDCXW) reported Equity Ratio of 0.01 for Q4 2025, down 101.21% on a YoY basis from 0.56 in Q4 2024, and up 92.64% quarter-over-quarter from 0.09 in Q3 2025.
Medicus Pharma (MDCXW) Equity Ratio (2023 - 2025) Analysis & Trends
Medicus Pharma has reported Equity Ratio for 3 years, with the latest figure at 0.01 in Q4 2025.
- For the quarter ending Q4 2025, Equity Ratio fell 101.21% year-over-year to 0.01; the trailing twelve-month figure through Dec 2025 stood at 0.01 (down 101.21% YoY), and the FY2025 full-year result was 0.01, down 101.21% from the prior year.
- Equity Ratio for Q4 2025 stood at 0.01, up from 0.09 in the prior quarter.
- The five-year high for Equity Ratio was 0.59 in Q4 2023, with the low at 0.09 in Q3 2025.
- Historically, Equity Ratio has averaged 0.28 across 3 years, with a median of 0.33 in 2025.
- Annual changes were most pronounced in 2024 — Equity Ratio retreated 5.45% — and 2025, when it sank 101.21%.
- Medicus Pharma's Equity Ratio stood at 0.59 in 2023, then dropped by 5.45% to 0.56 in 2024, then plunged by 101.21% to 0.01 in 2025.
- The last three Equity Ratio figures came in at 0.01 (Q4 2025), 0.09 (Q3 2025), and 0.27 (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Equity Ratio (Qtr) |
|---|---|---|---|---|---|
| 1 | Gsk | 93,699,046.73 Bn | 93,699,041.77 Bn | 7.76 Bn | - |
| 2 | Eli Lilly | 1,012.06 Bn | 1,006.77 Bn | 16.22 Bn | 0.27 |
| 3 | Johnson & Johnson | 560.67 Bn | 538.62 Bn | 15.96 Bn | 0.40 |
| 4 | AbbVie | 402.20 Bn | 392.85 Bn | 10.78 Bn | -0.05 |
| 5 | Merck | 298.59 Bn | 292.94 Bn | 12.09 Bn | 0.36 |
| 6 | Amgen | 188.77 Bn | 176.74 Bn | 5.87 Bn | 0.10 |
| 7 | Gilead Sciences | 160.22 Bn | 152.49 Bn | 5.52 Bn | 0.42 |
| 8 | Pfizer | 148.19 Bn | 135.42 Bn | -1.21 Bn | 0.43 |
| 9 | Bristol Myers Squibb | 116.72 Bn | 106.26 Bn | 8.07 Bn | 0.23 |
| 10 | Medicus Pharma | - | - | - | -0.01 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -0.01 |
| Sep 30, 2025 | -0.09 |
| Jun 30, 2025 | 0.27 |
| Mar 31, 2025 | 0.38 |
| Dec 31, 2024 | 0.56 |
| Dec 31, 2023 | 0.59 |